Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCH.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCH.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCH.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCTEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCTECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCTECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCTEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCTEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.86.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.86.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.86.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.86.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.86.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GK.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.13.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.13.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.13.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.13.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used